Author

Shafagh Valipour

National Cancer Institute

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Arfa MoshiriiD· 1 shared Jawad AkhtariD· 1 shared Jianghong Wu· 1 shared John Schneekloth· 1 shared Meiye JiangiD· 1 shared Mohd Saleem DariD· 1 shared Rolf E. SwensoniD· 1 shared Sai Reddy DodaiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Arfa MoshiriORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

SMYD3 protein degraders in HPV-negative head and neck squamous cell carcinoma.

Jawad Akhtar, Sai Reddy Doda, William Moore, Mohd Saleem Dar, Shafagh Valipour, Sohyoung Kim, Jianghong Wu, Yong Wan, Meiye Jiang, Arfa Moshiri, John Schneekloth, Sudipto Das, Þorkell Andrésson, Rolf E. Swenson, Vassiliki Saloura

This study develops SMYD3 proteolysis targeting chimeras (PROTACs) for HPV-negative head and neck squamous cell carcinoma, showing effective SMYD3 degradation and reduced oncogenic activity.

bioRxiv · Sep 29, 2026 · PreprintCancer Biology